For informational purposes only — not investment advice

← Back to signals

CRH

LONG

CRH PLC

Research: Finviz ↗·Perplexity ↗

Funds
5
Score
5.05
vs SPY
-26.5%
Stock return (since Q-end)
-22.4%
SPY return (since Q-end)
+4.0%
Current price
$82.65
Days to cover (short int.)
2.5d↓-6.3%
as of 2026-09-15

News Summary

Negative

CRH reported strong Q2 2026 results with 6% revenue growth and 13% net income growth, reaffirmed full-year guidance, and announced an $8.5 billion Arcosa acquisition to strengthen U.S. aggregates operations. However, the stock has declined sharply to 52-week lows amid analyst downgrades driven by macro headwinds in construction markets, integration/leverage risks tied to the large acquisition, and softer homebuilder confidence.

Red flags

  • •Stock fell to 52-week low of $85.12 following analyst downgrades; Wells Fargo cut price target by 19% ($132 to $107); Citigroup downgraded from Buy to Cautious (September 9)
  • •Large $8.5 billion acquisition announced with market concerns over integration risk, debt financing, leverage levels, and timing of $175M synergy realization
  • •U.S. construction market headwinds: softer homebuilder confidence driven by higher mortgage rates, labor shortages, and rising material costs
  • •Multiple analyst price target reductions in September despite Q2 beat, signaling shifted sentiment on execution and macro outlook

Funds Buying (5)

FundManagerShares Held∆ SharesPosition Value% of FundQoQStatus
Durable Capital PartnersHenry Ellenbogen2.7M+1.2M$285M2.8%+80%Existing
Third PointDan Loeb2.2M+295K$235M5.0%+16%Existing
Point72Steve Cohen2.0M+555K$219M0.3%+37%Existing
Duquesne Family OfficeStanley Druckenmiller554K+176K$59M1.4%+47%Existing
Soros Fund ManagementSoros Family Office124K+9K$13M0.2%+8%Existing

Shares Held and Position Value reflect total quarter-end holdings. ∆ Shares is the change from the prior quarter. % of Fund is the position's share of the fund's reported equity portfolio — it drives the size weighting in the conviction score.

Portfolio Context

Where CRH ranks in each buying fund's book, and the positions immediately around it. What a holding sits next to often says more about the thesis than the position size does.

Third Point

position #4 of this fund's book

  1. 1WARNER BROS DISCOVERY INC$533M
  2. 2AMAZON COM INC$417M
  3. 3ALPHABET INC$366M
  4. 4CRH PLC$235M
  5. 5TELEPHONE & DATA SYS INC$232M
  6. 6TAIWAN SEMICONDUCTOR MANUFAC$220M
  7. 7LIVE NATION ENTERTAINMENT IN$208M
Durable Capital Partners

position #15 of this fund's book

  1. 12FABRINET$339M
  2. 13PRIVIA HEALTH GROUP INC$299M
  3. 14UL SOLUTIONS INC$299M
  4. 15CRH PLC$285M
  5. 16SHOPIFY INC$267M
  6. 17CLEAN HARBORS INC$267M
  7. 18ROCKET COS INC$260M
Duquesne Family Office

position #19 of this fund's book

  1. 16Sandisk Corp$79M
  2. 17Revolution Medicines Inc$75M
  3. 18Bitdeer Technologies Group$65M
  4. 19Crh Plc$59M
  5. 20Delta Air Lines Inc$56M
  6. 21Fluor Corp$51M
  7. 22D R Horton Inc$49M

Values are quarter-end position sizes. Shown only for funds where CRH ranks inside their 40 largest equity positions — below that, neighbouring names carry no signal. Adjacency is an inference about a fund's reasoning, not a disclosure of it.

Beneficial Ownership (13D/13G)

FilerFormShares% of ClassFiledSrc
Vanguard Capital ManagementSC 13G50.1M7.5%2026-04-28↗

SC 13D = active intent to influence control (10-day filing deadline after crossing 5%). SC 13G = passive accumulation, no intent to influence control.